Corcept Therapeutics Incorporated
CORT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $128 | $136 | $66 | $78 |
| Short-Term Investments | $256 | $233 | $365 | $146 |
| Receivables | $58 | $57 | $47 | $29 |
| Inventory | $12 | $8 | $6 | $5 |
| Other Curr. Assets | $8 | $26 | $15 | $9 |
| Total Curr. Assets | $472 | $459 | $499 | $266 |
| Property Plant & Equip (Net) | $8 | $0 | $2 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $220 | $57 | $5 | $112 |
| Tax Assets | $131 | $91 | $61 | $27 |
| Other NC Assets | $10 | $15 | $16 | $16 |
| Total NC Assets | $369 | $163 | $84 | $157 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $841 | $622 | $583 | $424 |
| Liabilities | – | – | – | – |
| Payables | $15 | $17 | $12 | $7 |
| Short-Term Debt | $1 | $0 | $1 | $1 |
| Tax Payable | $0 | $3 | $0 | $1 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $83 | $60 | $44 | $26 |
| Total Curr. Liab. | $141 | $105 | $72 | $48 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $14 | $10 | $9 | $0 |
| Total NC Liab. | $20 | $10 | $9 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $7 | $0 | $1 | $1 |
| Total Liabilities | $161 | $115 | $82 | $48 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $544 | $403 | $296 | $195 |
| AOCI | -$0 | $1 | -$1 | -$0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $680 | $507 | $502 | $376 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $841 | $622 | $583 | $424 |
| Net Debt | -$127 | -$135 | -$65 | -$77 |